GO BEYOND
LIVE

Serial Number

98699055

Owner

Empower Clinic Services, L.L.C.

Attorney

John A. Yates

Filing Date

Aug 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GO BEYOND Trademark

Serial Number: 98699055

GO BEYOND is a trademark filed by Empower Clinic Services, L.L.C. on August 14, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Empower Clinic Services, L.L.C. (21 trademarks)

7601 N. Sam Houston Pkwy. W.
Houston, TX 77064

Entity Type: 16

Trademark Details

Filing Date

August 14, 2024

Registration Date

Not Registered

Published for Opposition

May 20, 2025

Goods & Services

Conducting regulatory compliance consulting for others in the pharmaceutical industry in the field of pharmaceuticals

Retail pharmacy services; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Supply chain management services for others in the pharmaceutical industry in the field of pharmaceuticals

Medical syringes; disposable syringes; syringe barrels; luer lock syringe barrels; injection needles for medical use; vial adapters for syringes; trocars; and containers adapted for the disposal of medical instruments and syringes.

Pharmaceutical drug development services and contract pharmaceutical drug development services; Research and development services of pharmaceutical products and preparations; Research and development services of pharmaceutical products and preparations for others; Conducting research, formulation development, clinical trials, packaging design sevices, and quality assurance for others in the pharmaceutical industry in the field of pharmaceuticals; Conducting post-marketing product support for others in the pharmaceutical industry in the field of pharmaceuticals, namely, post-market surveillance, clinical trials, and studies to further assess the safety, efficacy, or optimal use of approved products; Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Laboratory analysis for others in the field of pharmaceuticals; Laboratory services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards.

Pharmaceutical compounding services; preparation of prescriptions by pharmacists; pharmaceutical consultation services.

Custom manufacture of pharmaceuticals; contract manufacturing of pharmaceuticals; contract manufacturing for others; contract manufacturing for others in the field of pharmacology, microbiology, toxicology, and biotechnology.

Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous nutrition, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, women's health, and gender-affirming care; pharmaceutical preparations for intravenous therapy, namely, amino acids, minerals, vitamins, antihistamines, and anesthetics prepared for direct administration into a vein; pharmaceutical preparations for intravenous therapy for treatment of inflammation, pain, blood clots, nausea, and vomiting; pharmaceutical preparations for injectable therapy, namely, amino acids, minerals, vitamins, antihistamines, and anesthetics prepared for administration from a needle; pharmaceutical preparations for injectable therapy for treatment of inflammation, pain, blood clots, nausea, and vomiting; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes.

Filing History

CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 22, 2026 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 20, 2026 AITU
TEAS STATEMENT OF USE RECEIVED
Jan 15, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Jan 15, 2026 ERTD
SOU TEAS EXTENSION RECEIVED
Jan 15, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 15, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 15, 2024 NWOS
NEW APPLICATION ENTERED
Aug 14, 2024 NWAP